NASDAQ:KROS | Profit Breakdown | Keros Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2019-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30$0.00-$30.94M-$28.71M-$28.71M
2026-03-31$367,000.00-$25.88M-$23.71M-$23.71M
2025-12-31$385,000.00-$29.27M-$24.98M-$23.46M
2025-09-30$14.26M-$15.38M-$8.7M-$7.28M
2025-06-30$18.17M-$39.82M-$32.92M-$30.7M
2025-03-31$211.25M$152.04M$158.49M$148.45M
2024-12-31$3.04M-$53.25M-$45.73M-$46.03M
2024-09-30$388,000.00-$58.66M-$52.96M-$52.96M
2024-06-30$37,000.00-$50.44M-$45.26M-$45.26M
2024-03-31$83,000.00-$48.48M-$43.11M-$43.11M
2023-12-31$143,000.00-$46.46M-$40.24M
2023-09-30$8,000.00-$43.28M-$39.44M
2023-06-30$0.00-$41.34M-$37.51M
2023-03-31$0.00-$38.87M-$35.8M
2022-12-31$0.00-$31.96M-$29.72M-$29.72M
2022-09-30$0.00-$27.98M-$23.51M-$23.51M
2022-06-30$0.00-$30.73M-$27.27M-$27.27M
2022-03-31-$24.13M-$24.19M-$24.19M
2021-12-31$20M-$4.87M-$4.94M-$6.94M
2021-09-30$0.00-$20.2M-$20.34M-$20.3M
2021-06-30$100,000.00-$15.54M-$15.62M-$15.62M
2021-03-31-$15.77M-$15.84M-$15.89M
2020-12-31$0.00-$13.29M-$10.68M-$10.68M
2020-09-30$0.00-$11.95M-$12.04M-$12.04M
2020-06-30$0.00-$10.91M-$10.76M-$10.76M
2020-03-31$0.00-$10.5M-$12.06M-$11.89M
2019-12-31$2.5M-$2.73M-$2.75M-$2.75M
2019-09-30$2.5M-$2.33M-$3.55M-$3.55M
2019-06-30$2.5M-$2.65M-$2.85M-$2.85M
2019-03-31$2.5M-$2.86M-$3.18M-$3.18M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$244.06M$67.57M$91.9M$87.01M
2024-12-31$3.55M-$210.83M-$187.05M-$187.35M
2023-12-31$151,000.00-$169.94M-$152.99M-$152.99M
2022-12-31$0.00-$114.79M-$104.68M-$104.68M
2021-12-31$20.1M-$56.37M-$56.73M-$58.74M
2020-12-31$0.00-$46.66M-$45.53M-$45.36M
2019-12-31$10M-$10.56M-$12.34M-$12.34M